Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers - Drug Trials For Money - Paid Clinical Trials

A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers

A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers
Conditions:   Colorectal Cancer;   Gastric Cancer;   Pancreatic Cancer;   Ovarian Cancer
Intervention:   Drug: CUE-102
Sponsor:   Cue Biopharma
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 8, 2022 / by / in
Comments